3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
21
Withdrawn
3
Terminated
3
Unknown
2
Recruiting
1
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
144
Gastrointestinal
32
Breast
27
Head & Neck
26
Genitourinary
25
Thoracic
23
Dermatologic
15
Sarcoma
8
Other solid neoplasm
6
CNS
5
Other hematologic neoplasm
4
Lymphoid
4
NET
2
Endocrine
2
Plasma cell
1
Other neoplasm
1
Conditions
Precancerous Conditions
7
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Obesity-Related Malignant Neoplasm
3
Neoplasms
3
Myelodysplastic Syndromes
3
Lymphoma
3
Leukemia, Myeloid, Acute
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Leukemia
3
Primary Myelofibrosis
2
Preleukemia
2
Neoplasms by Histologic Type
2
Myeloproliferative Disorders
2
Lymphoproliferative Disorders
2
Lymphatic Diseases
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Myeloid
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Leukemia, Lymphoid
2
Leukemia, Biphenotypic, Acute
2
Leukemia, B-Cell
2
Immunoproliferative Disorders
2
Immune System Diseases
2
Hematologic Diseases
2
Bone Marrow Diseases
2
Advanced Malignant Neoplasm
2
Waldenstrom Macroglobulinemia
1
Waitlist Control
1
Uterine Prolapse
1
Uterine Cervical Neoplasms
1
Interventions
Robotic Surgical Procedures
1
Hysterectomy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Uterine Cervical Neoplasms
×
Other neoplasm
×
Clear all
NCT07120945
2026-06-02
Embrace Gyn
Medtronic - MITG
Phase NA
Active not recruiting
70 enrolled